multifunctional antibodies that create immune synapses
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
70
NCT06672185
ARC101 in Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 5, 2025
Completion: Aug 1, 2028
Loading map...